新型GLP-1口服药抑制零食摄入效果不及注射剂型

格隆汇
Yesterday
彭博情报(BI)最新研究显示,使用GLP-1口服药减肥的用户,其零食摄入量的减少幅度低于通过注射接受该治疗的用户。与注射GLP-1的用户相比,口服药物的用户中表示减少了咸味零食、烘焙食品及其他品类摄入的比例更低。BI报告指出,未来几年口服药的推出预计将推动GLP-1使用量上升,随着整体普及率的提高,其对食品公司的总影响也将持续扩大。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10